Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Kevetrin - Hoping it will come back into the SPOT light!

A good deal for a younger BIO - mid phase on fierce bio:

https://www.fiercebiotech.com/biotech/bayer-pays-400m-upfront-to-buy-into-loxo-cancer-drugs

I liked these snippets:

With filings for approval in the U.S. and Europe already in the works, Loxo has been emboldened to predict the deal will generate $1 billion over the next few years.

That figure reflects the industry’s appetite for cancer drugs and strength of the data generated by larotrectinib.

All told, Loxo could receive $1.55 billion, almost half of which is due to land in its bank account by the end of next year. The numbers proved compelling enough for Loxo to drop its go-solo plans.

Loxo was approached by large biopharma companies after posting data on larotrectinib earlier this year, CEO Joshua Bilenker, M.D., said on a call with investors. This led Loxo to evaluate the various deal models proposed by potential partners against its existing go it alone plans, before homing in Bayer’s offer as the best fit.

Kevetrin can possibly hold the key to P53 the GUARDIAN ANGEL GENE
Think of all the possibilities with combo trials...unreal. We just need to prove the MoA in this phase 2 Ovarian trial. Hopefully we hear soon.